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Cannabidiol (CBD) has been established to have both acute and long-lasting effects
to reduce fear memory expression. The long-lasting impact might be mediated by an
enhancement of memory extinction or an impairment of memory reconsolidation. Here,
we directly compared the effects of i.p. injections of cannabidiol (10 mg/kg) with those
of the NMDA receptor antagonist MK-801 (0.1 mg/kg) and partial agonist D-cycloserine
(DCS; 15 mg/kg) in order to determine the mnemonic basis of long-term fear reduction.
We showed that under conditions of strong fear conditioning, CBD reduced contextual
fear memory expression both acutely during the extinction session as well as later at a
fear retention test. The latter test reduction was replicated by DCS, but MK-801 instead
elevated test freezing. In contrast, when initial conditioning was weaker, CBD and MK-
801 had similar effects to increase freezing at the fear retention test relative to vehicle
controls, whereas DCS had no observable impact. This pattern of results is consistent
with CBD enhancing contextual fear memory extinction when the initial conditioning is
strong, but impairing extinction when conditioning is weak. This bidirectional effect of
CBD may be related to stress levels induced by conditioning and evoked at retrieval
during extinction, rather than the strength of the memory per se.
Keywords: memory, extinction, fear, contextual, cannabinoid
INTRODUCTION
Cannabidiol (CBD) is the major non-psychotropic constituent of the Cannabis plant and
has anxiolytic therapeutic potential. Acute administration of CBD decreases the expression of
contextual conditioned fear memories in rats (Resstel et al., 2006; Lemos et al., 2010; but see
Marinho et al., 2015) as well as reducing physiological fear-related responses in humans (Fusar-
Poli et al., 2009). These acute effects may be mediated by a variety of central loci, including the
amygdala (Fusar-Poli et al., 2009), prelimbic cortex (Lemos et al., 2010), and bed nucleus of the
stria terminalis (Gomes et al., 2012). Moreover, the fear-reducing impact of CBD is likely to be via
its action as a 5-HT1A partial agonist (Gomes et al., 2012; Fogaça et al., 2014).
CBD can also result in long-lasting fear reduction, when combined with either extinction
training or brief memory reactivation/destabilization to impair reconsolidation (Bitencourt et al.,
2008; Stern et al., 2012; Das et al., 2013; Do Monte et al., 2013; Gazarini et al., 2015). Infusion of
CBD intra-cerebroventricularly (Bitencourt et al., 2008) or into the infralimbic cortex (Do Monte
et al., 2013) prior to extinction training in rats enhanced the subsequent reduction in contextual
fear expression indirectly via CB1 receptor activation. Moreover, CBD also enhanced the beneficial
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impact of extinction training in a human fear conditioning
setting (Das et al., 2013). Similarly, CBD might diminish fear
expression when combined with brief memory reactivation
and the engagement of destabilization/reconsolidation processes.
Systemic injection of CBD immediately after brief memory
retrieval resulted in a long-lasting subsequent impairment in
contextual freezing (Stern et al., 2012). This effect was dependent
upon CB1R activity and was also observed in a model of post-
traumatic stress disorder, albeit necessitating pharmacological
enhancement of memory destabilization (Gazarini et al.,
2015).
The apparent effect of CBD both to enhance extinction
and impair reconsolidation is of particular note, given that
other treatments have a common impact on both processes,
thereby leading to bidirectional effects on fear expression
(Pedreira and Maldonado, 2003; Lee et al., 2006; Tronson
et al., 2006; Schramm et al., 2016), or are selective for
only one of the processes (Suzuki et al., 2004; de la Fuente
et al., 2011; Tronson et al., 2012). However, reconsolidation
impairments are not easily distinguished from potentiation
of extinction (e.g., Trent et al., 2015). Therefore, it remains
unclear whether the aforementioned studies do indeed reflect
distinct mechanisms of action to produce similar reductions
in fear, especially given the common dependence upon CB1Rs.
While hippocampal CB1R antagonism by AM251 appears to
produce the opposite effects to CBD (de Oliveira Alvares
et al., 2008), intra-amygdala infusion of AM251 impairs, rather
than enhances, fear memory reconsolidation (Ratano et al.,
2014). However, hippocampal CB1/2R agonism does impair
contextual fear memory reconsolidation (Santana et al., 2016).
With systemic administration, CB1R antagonism has been shown
previously to impair contextual fear memory extinction (Suzuki
et al., 2004) and memory destabilization (Suzuki et al., 2008),
whereas CB1R agonists enhance destabilization without reducing
contextual freezing alone (Lee and Flavell, 2014). Therefore,
the somewhat mixed picture concerning CB1R involvement
in reconsolidation and extinction has implications for the
interpretation of CB1R-dependent CBD effects on contextual
fear.
A further complication is the lack of no-extinction control
groups in the CBD extinction studies (Bitencourt et al.,
2008; Das et al., 2013; Do Monte et al., 2013). While not
as routinely implemented as in reconsolidation studies, no-
extinction controls are important to rule out potential direct
long-lasting effects of CBD upon the subsequent test. This is
especially pertinent as CBD has been shown to reduce cue-
induced heroin seeking when given 24 h, but not 30 min,
prior to the test (Ren et al., 2009), and has long-lasting anti-
depressant effects up to 14 d post-injection (Linge et al., 2016).
Therefore, here we revisited the putative effect of CBD to enhance
contextual fear memory extinction, with the addition of no-
extinction controls. Moreover, we compared the effect of CBD
against the impact of systemic administration of MK-801 and
D-cycloserine (DCS), given that NMDA receptor antagonism
and partial agonism have been established to impair (Suzuki
et al., 2004) and enhance (Yamada et al., 2009, 2011) context fear
memory extinction, respectively.
MATERIALS AND METHODS
Subjects
100 experimentally-naïve male Lister Hooded Rats (Charles
River, UK; aged 7–8 weeks at the start of experimental
procedures) were housed in quads under a 12 h light cycle (lights
on at 0700) in a specialist animal facility. Individually-ventilated
cages contained aspen chip bedding and a plexiglass tunnel for
environmental enrichment. Rats had free access to food and
water other than during behavioral sessions. Experiments took
place between 0900 and 1200 in a behavioral laboratory. At the
end of the experiment, animals were humanely killed using a
rising concentration of CO2. All procedures were approved by
the local animal welfare and ethical review board and carried out
in accordance with the United Kingdom 1986 Animals (Scientific
Procedures) Act, Amendment Regulations 2012 (PPL 70/7662).
Drugs
Drugs were administered intraperitoneally (1 ml/kg) 30 min
prior to extinction sessions. CBD (THC pharm, Germany; 10
mg/kg) was dissolved in DMSO and diluted to a final vehicle of
20% DMSO in Saline with 0.1% Tween 80 immediately prior to
use. MK-801 (Sigma, UK; 0.1 mg/kg) and D-cycloserine (DCS;
Sigma, UK; 15 mg/kg) were dissolved in saline vehicle and stored
at −10◦C until use. Doses of drugs were taken from published
literature showing modulatory effects on fear memory (Lee et al.,
2006; Stern et al., 2012).
Behavioural Procedures
All behavioral procedures were carried out in conditioning
chambers (MedAssociates, VT) as previously described (Lee and
Hynds 2013), with freezing behavior automatically recorded by
Videotracking software (Viewpoint Life Sciences, France). All
rats received the same behavioral training, apart from a single
difference in the conditioning session.
One day prior to conditioning, rats were exposed twice to
the conditioning chamber for 10 min on each occasion, with a
60-min ITI. Conditioning consisted of either a 7-min or a 10-
min session for weak and strong conditioning, respectively. For
both conditions, there was a 5-min pre-shock period, followed
by exposure to a sequence of 0.5-mA, 1-s footshocks at 300 s
and 341 s (as well as 402, 423, 484, and 525 s for the strong
conditioning). On the next day, rats were given i.p. injections
30 min prior to a 20-min re-exposure to the context (extinction
session). Finally, the day after extinction, rats were tested in a
5-min context re-exposure.
Statistical Analyses
Data are presented as mean + SEM. Contextual freezing at
test was analyzed in JASP (JASP Team, 2016) using 2-way
ANOVA for a direct comparison of extinction and no-extinction
conditions, followed by planned one-way ANOVA comparisons
of drug effects within each condition. The extinction sessions
(sub-divided into four 5-min bins) were analyzed bymixed 2-way
ANOVA. Mauchly’s W was used as a test of sphericity, and the
Greenhouse-Geisser correction employed when the assumption
of sphericity was violated. η2p was used as an estimate of effect size
Frontiers in Pharmacology | www.frontiersin.org 2 December 2016 | Volume 7 | Article 493
Song et al. Cannabidiol and Context Fear Memory Extinction
and BF10 is also reported as the outcome of Bayesian analyses for
the estimation of posterior probability (Jarosz and Wiley, 2014).
RESULTS
We initially used a mild conditioning procedure that was similar
in intensity to our previous work. With two mild footshocks, a
moderate level of contextual freezing (35–40%) was observed at
the start of the extinction session. In comparing the extinction
and no-extinction conditions (Figure 1), while there was a
significant effect of the extinction session [F(1, 23) = 14.1, p =
0.001, η2p = 0.38, BF10 = 37.7], there was no effect of CBD
[F(1, 23) = 2.4, p = 0.14, η
2
p = 0.09, BF10 = 0.91] or CBD
x extinction interaction [F(1, 23) = 1.8, p = 0.19, η
2
p = 0.07,
BF10 = 0.84].
Planned comparison of the extinction condition revealed a
significant effect of CBD to elevate contextual freezing at test
[F(1, 12) = 7.1, p = 0.02, η
2
p = 0.37, BF10 = 3.2], but
no observable acute effect on contextual freezing during the
extinction session [CBD: F(1, 12) = 0.11, p = 0.74, η
2
p = 0.009,
BF10 = 0.43; CBD x bin: F(3, 36) = 0.28, p = 0.84, η
2
p =
0.02, BF10 = 0.23]. Surprisingly, there was no evidence for
within-session extinction [F(3, 36) = 1.7, p = 0.19, η
2
p = 0.12,
BF10 = 0.69]. In the no-extinction control condition, planned
comparisons revealed no effect of CBD at test [F(1, 11) = 0.013,
p = 0.91, η2p = 0.001, BF10 = 0.46]. Therefore, CBD appears
to impair the normal reduction in contextual freezing observed
following extinction training in an effect that is not attributable
to direct effects of CBD injection upon test performance on the
next day.
In order to disambiguate whether the CBD-induced elevation
of freezing reflects an impairment of extinction or perhaps
an enhancement of reconsolidation, we administered MK-801
and DCS under the same experimental conditions. Injection
of MK-801 appeared to impair the extinction of contextual
freezing, whereas DCS had no observable effect (Figure 2).
ANOVA revealed a significant difference between the groups
[F(2, 17) = 14.6, p < 0.001, η
2
p = 0.63, BF10 = 125], with
post-hoc comparisons (p< 0.05) showing that the MK-801 group
displayed higher levels of contextual freezing than both the Saline
control group and the DCS-injected rats (the latter two groups
not differing from each other). This difference at test was not
attributable to pre-existing differences at the extinction session,
with no effect of group [F(2, 17) = 1.30, p = 0.30, η
2
p = 0.13,
BF10 = 0.57] or group x bin [F(3.6, 30.4) = 0.67, p = 0.60, η
2
p
= 0.07, BF10 = 0.16] interaction. While there was a significant
effect of bin [F(1.8, 30.4) = 3.88, p = 0.036, η
2
p = 0.19, BF10 =
3.90], this was not driven by a decline in freezing over the
course of the session, and so there was again little evidence for
within-session extinction.
Given the unexpected effects of CBD observed above, in terms
of our failure to replicate the reduction in contextual freezing
observed previously, the lack of acute effect of CBD at the
extinction session and the lack of within-session extinction, we
repeated the experiment using stronger conditioning parameters
involving 6 mild footshocks. In comparing the extinction and
no-extinction conditions (Figure 3), while there was a significant
effect of the extinction session [F(1, 24) = 47.4, p < 0.001,
η
2
p = 0.66, BF10 = 27.5 × 10
3], there was no effect of CBD
[F(1, 24) = 1.1, p = 0.30, η
2
p = 0.05, BF10 = 0.52] or CBD
x extinction interaction [F(1, 24) = 3.0, p = 0.10, η
2
p = 0.11,
BF10 = 1.2]. Planned comparison of the extinction condition
revealed a significant effect of CBD to reduce contextual freezing
at test [F(1, 12) = 7.3, p = 0.02, η
2
p = 0.38, BF10 = 3.3],
as well as a moderate acute impairment of contextual freezing
during the extinction session [CBD: F(1, 12) = 5.4, p = 0.04,
η
2
p = 0.31, BF10 = 1.1; CBD x bin: F(3, 36) = 1.9, p = 0.15,
η
2
p = 0.16, BF10 = 0.90]. Under these conditions there was
a significant reduction in contextual freezing during the course
of the extinction session [F(3, 36) = 5.2, p = 0.004, η
2
p = 0.30,
BF10 = 18.3]. In the no-extinction control condition, planned
comparisons revealed no effect of CBD at test [F(1, 12) = 0.15,
p = 0.70, η2p = 0.012, BF10 = 0.47]. Therefore, with stronger
conditioning CBD appears to enhance the normal reduction in
contextual freezing observed following extinction training in an
effect that is not attributable to direct effects of CBD injection
upon test performance on the next day.
FIGURE 1 | Pre-extinction CBD attenuates the subsequent decline in contextual freezing following weak conditioning. CBD was injected 30 min prior to
the extinction session, or in the absence of an extinction session. There were no acute effects of CBD during the extinction session itself (A), but there was an
extinction-dependent effect at the subsequent test (B). Vehicle-injected rats froze at lower levels than CBD-treated rats. N = 6–8 per group. *p < 0.05.
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FIGURE 2 | Pre-extinction MK-801 attenuates the subsequent decline in contextual freezing following weak conditioning. MK-801 and DCS were
injected 30 min prior to the extinction session. There were no acute effects of either drug during the extinction session itself (A). MK-801, but not DCS, increased
contextual freezing at the subsequent test (B). N = 6–7 per group. *p < 0.05.
FIGURE 3 | Pre-extinction CBD potentiates the subsequent decline in contextual freezing following strong conditioning. CBD was injected 30 min prior to
the extinction session, or in the absence of an extinction session. CBD acutely reduced contextual freezing during the extinction session (A), as well as enhancing the
extinction-dependent reduction of freezing at the subsequent test (B). N = 7 per group. *p < 0.05.
Again, to disambiguate extinction and reconsolidation
accounts of the CBD-induced reduction in freezing, we injected
MK-801 and DCS in the same stronger conditioning setting.
Injection of DCS appeared to potentiate the extinction of
contextual freezing, whereas MK-801 had no observable effect
(Figure 4). ANOVA revealed a significant difference between the
groups [F(2, 21) = 5.31, p = 0.014, η
2
p = 0.34, BF10 = 4.5],
with post-hoc comparisons (p < 0.05) showing that the DCS
group displayed lower levels of contextual freezing than both
the Saline control group and the MK-801-injected rats (the latter
two groups not differing from each other). This difference at test
was not attributable to pre-existing differences at the extinction
session, as the effect of group [F(2, 21) = 6.27, p = 0.007, η
2
p =
0.37, BF10 = 7.8) and group x bin interaction [F(4.0, 42.4) = 3.78,
p = 0.01, η2p = 0.27, BF10 = 12.1] were both driven by lower
freezing in the MK-801-injected rats. Analyses of the simple
main effects of group at each bin revealed significant effects in
the 1st and 2nd bins only [F’s(2, 21) > 5.25, p’s < 0.015, η
2
p’s
> 0.33, BF10’s = 4.3], for which post-hoc pairwise comparisons
confirmed that the MK-801 group was lower than the saline
group, with no other differences. As with the CBD experiment,
for these stronger conditioning parameters there was a significant
reduction in contextual freezing over the course of the extinction
session [F(2.0, 42.4) = 11.8, p < 0.001, η
2
p = 0.36, BF10 = 12.1],
apart from in the MK-801 group.
DISCUSSION
Here we demonstrate that i.p. CBD and MK-801 injections
30 min prior to extinction training had a common effect of
increasing subsequent contextual freezing when contextual fear
conditioning was relatively weak. In contrast, CBD replicated the
effect of DCS to reduce contextual freezing when conditioning
was stronger. These effects of CBD were critically dependent
upon the extinction training, as CBD alone had no effect upon
subsequent contextual freezing. These results suggest that the
long-term impact of CBD on extinction depends upon the prior
conditioning experience.
Under the strong conditioning procedure, CBD reduced
subsequent freezing by a similar extent to DCS (CBD: 29.5 ±
2.5; DCS: 28.7 ± 9.0). In contrast, MK-801 had no observable
effect. Given that DCS has previously been shown to potentiate
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FIGURE 4 | Pre-extinction DCS reduces contextual freezing following strong conditioning. MK-801 and DCS were injected 30 min prior to the extinction
session. MK-801 acutely reduced contextual freezing during the first 2 bins of the extinction session (A). DCS, but not MK-801, reduced contextual freezing at the
subsequent test (B). N = 8 per group. *p < 0.05.
contextual fear memory extinction (Yamada et al., 2011), this
suggests that CBD also enhances extinction. In contrast, and
somewhat surprisingly, there was no evidence that MK-801
impaired extinction under the same conditions. While there was
no non-extinction control in the MK-801/DCS experiment, the
no-extinction control in the CBD experiment suggests that the
20-min extinction session did induce a meaningful reduction
in contextual freezing. This is consistent with the literature
indicating that DCS only potentiates extinction when there is
significant reduction in fear induced by the extinction training
itself (Bolkan and Lattal, 2014). Therefore, it remains unclear
why MK-801 did not impair this extinction-induced reduction
in freezing, especially as it did under the weaker conditioning
procedure. Indeed, there was no visual indication of an extinction
impairment, as might have been expected with a ceiling effect
were the freezing reductions in control animals too modest to
observe a significant impairment. Nevertheless, the common
effect of CBD and DCS supports the interpretation that each
treatment reduced freezing through a potentiation of memory
extinction.
While the combination of drug treatment and extinction
training to reduce freezing is certainly consistent with an
enhancement of extinction, studies of memory extinction rarely
rule out alternative interpretations based upon long-lasting direct
effects of drug treatment on the test itself. For i.p. injections
of DCS, its effect on contextual freezing was not shown to
be extinction-dependent (Yamada et al., 2011). However, when
infused into the hippocampus, DCS did not have long-lasting
direct effects on contextual freezing in the absence of extinction
training (Bolkan and Lattal, 2014). Moreover, i.p. DCS reduced
contextual freezing only when given before a long extinction
session, but increased freezing when the extinction session
was shorter (Yamada et al., 2009), demonstrating that these
bidirectional effects must be attributable to the nature of the
extinction session. In contrast, prior demonstrations of CBD
reducing contextual freezing have not shown the effects to
be dependent upon the extinction training (Bitencourt et al.,
2008; Do Monte et al., 2013). CBD has been shown to have
long-lasting antidepressant effects, reducing hyperactivity in an
olfactory bulbectomy model of depression in mice (Linge et al.,
2016). While these effects were observed with a higher single
dose of CBD (50 mg/kg c.f. 10 mg/kg used here), a long-
lasting modulatory effect on locomotor activity would likely
impact upon the conditioned freezing measure of fear used here.
However, in the absence of extinction training, CBD had no
impact upon contextual freezing 24 h later. Therefore, CBD likely
does potentiate contextual fear memory extinction.
The long-lasting reduction in contextual fear was preceded by
an acute effect of CBD to reduce the expression of contextual
freezing during the extinction session itself. This acute effect
further supports the need for the aforementioned no-extinction
controls, in order to rule out any direct persistent effects of
CBD to reduce freezing. While CBD has been shown to reduce
contextual fear memory expression (Resstel et al., 2006; Lemos
et al., 2010) but see (Marinho et al., 2015), in the previous
studies of contextual fear memory extinction CBD did not have
an acute effect when it did potentiate extinction (Bitencourt
et al., 2008; Do Monte et al., 2013). These discrepant effects
might be related to the route of administration. Prior extinction
studies have infused CBD directly into the infralimbic cortex
(Do Monte et al., 2013) or intracerebroventricularly (Bitencourt
et al., 2008), whereas the acute fear-reducing effect of CBD
appears to involve the prelimbic cortex (Lemos et al., 2010),
bed nucleus of the stria terminalis (Gomes et al., 2012), and
perhaps the amygdala (Fusar-Poli et al., 2009). Therefore, while
direct intracranial infusions dissociate the acute and long-lasting
impacts of CBD, systemic injections appear able to induce both
effects, presumably via actions in those dissociable neural loci.
This is of translational relevance as both acute fear reduction
and long-lasting enhancements in fear extinction have clinical
benefits.
While the effects of CBD in our strong conditioning procedure
are consistent with prior literature, the results from our weak
conditioning experiments are less so. Under these conditions,
the extinction session appeared to reduce contextual freezing to
near baseline levels, such that while MK-801 impaired extinction
to increase freezing, DCS did not further reduce freezing.
Therefore, we might have expected CBD to replicate the effect
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of DCS (as it did in the stronger conditioning experiments),
resulting in no modulation of contextual freezing. Instead,
CBD replicated the effect of MK-801 to increase freezing at
test. No-extinction controls confirmed that this elevation in
freezing at test was not a direct effect of CBD, as might be
predicted from a putative CBD-induced long-lasting attenuation
of activity (Linge et al., 2016). Therefore, the effect of CBD
is consistent with an impairment in memory extinction. The
alternative explanation of an enhancement of reconsolidation
is not consistent with the effects of MK-801 and DCS, nor
is it supported by previous demonstrations that CBD impairs,
rather than enhances reconsolidation (Stern et al., 2012). Why
CBD should impair extinction when conditioning is weak is
unclear. Although bidirectional memory modulatory effects with
the same treatment have been observed previously (Suzuki et al.,
2004; Lee et al., 2006), including with strength of conditioning
being the only variable (Eisenberg et al., 2003), these have
been interpreted as qualitatively similar effects on dissociable
mnemonic processes (e.g., impairment of extinction to increase
memory expression vs. impairment of reconsolidation to reduce
memory expression). A bidirectional effect on extinction based
upon the strength of the memory, to our knowledge, has not been
previously reported.
There are two possible explanations for why the strength of
conditioning should reverse the impact of CBD on extinction:
Neuroanatomical competition and the differential stress levels
evoked during extinction. In a series of studies of the impact
of intra-medial prefrontal cortical infusions of CBD, Guimaraes
and colleagues have previously demonstrated opposing effects
of CBD depending upon the locus of infusion and levels
of stress (Fogaça et al., 2014; Marinho et al., 2015). Intra-
prelimbic infusions of CBD reduced the expression of contextual
fear conditioning, whereas infusions into the infralimbic
cortex increased contextual freezing. Given that our systemic
injections of CBD here acutely inhibited contextual freezing
during the extinction session following strong conditioning,
these conditioning parameters (identical to those used in the
infusion studies) might have biased the primary central locus
of activity of CBD to the prelimbic cortex. However, while
there has been no study to date of the impact of intra-
prelimbic CBD infusions upon fear memory extinction, the
neuroanatomical underpinnings of fear memory extinction
implicates the infralimbic cortex, rather than the prelimic
cortex (Sotres-Bayon and Quirk, 2010), consistent with the
observation that intra-infralimbic CBD enhances contextual
fear memory extinction (Do Monte et al., 2013). Therefore,
while the neuroanatomical locus of effect (and indeed also the
neurochemical and neurophysiological basis) of systemically-
injected CBD in the current study remains to be determined, it
is perhaps unlikely that our bidirectional results can be attributed
to differential neuroanatomical loci of effects.
The same aforementioned studies of medial prefrontal cortical
infusions also revealed apparent effects of stress levels upon
the impact of CBD (Fogaça et al., 2014; Marinho et al., 2015).
While prelimbic infusions of CBD reduced the expression of
contextual freezing, they also increasedmeasures of anxiety in the
elevated plus maze (Fogaça et al., 2014). This anxiogenic effect
is likely due to the relatively low stress levels induced in the
elevated plus maze, as compared to contextual fear conditioning,
as when testing was preceded by restraint stress to increase the
stress levels present in the plus maze, the impact of CBD was
reversed to reduce anxiety (Fogaça et al., 2014). For infralimbic
infusions, the pattern of results was largely the reverse of those
observed with prelimbic infusions, but restraint stress blocked,
rather than reversed, the anxiolytic effect of CBD (Marinho
et al., 2015). Although these results are related specifically to the
acute expression of fear and anxiety, they reveal the possibility
that the longer-term impact of CBD in relation to its effect
on extinction might similarly be modulated by the stress levels
present during the extinction session. One clear prediction
would be that restraint stress prior to extinction following
weaker conditioning would block the effect of CBD to impair
extinction.
In summary, CBD had bidirectional effects on the extinction
of contextual fear conditioning, depending on the nature
of the initial fear conditioning. Nevertheless, in the more
translationally-relevant stronger conditioning setting, CBD both
acutely inhibited fear expression and enhanced extinction to
produce longer lasting reductions in fear. These observations
provide further support for the potential translational use of CBD
in conditions such as posttraumatic stress disorder and specific
phobias.
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